Fmc-Blythe Desert Dialysis in Blythe, California - Dialysis Center

Fmc-Blythe Desert Dialysis is a medicare approved dialysis facility center in Blythe, California and it has 13 dialysis stations. It is located in Riverside county at 737 W. Hobson Way, Blythe, CA, 92225. You can reach out to the office of Fmc-Blythe Desert Dialysis at (760) 922-4415. This dialysis clinic is managed and/or owned by Fresenius Medical Care. Fmc-Blythe Desert Dialysis has the following ownership type - Profit. It was first certified by medicare in October, 1997. The medicare id for this facility is 052812 and it accepts patients under medicare ESRD program.

Name	Fmc-Blythe Desert Dialysis
Location	737 W. Hobson Way, Blythe, California
No. of Dialysis Stations	13
Medicare ID	052812
Managed By	Fresenius Medical Care
Ownership Type	Profit
Late Shifts	No

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with Fmc-Blythe Desert Dialysis from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number	1932211836
Organization Name	Blythe Desert Dialysis
Doing Business As	Bio-medical Applications Of California, Inc.
Address	737 W Hobsonway Blythe, California, 92225
Phone Number	(760) 922-4415

Dialysis patients with Hemoglobin data	14
Medicare patients who had average hemoglobin (hgb) less than 10 g/dL	7

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

• Hemodialysis

  Adult patients getting regular hemodialysis at the center	31
  Adult patient months included in Kt/V greater than or equal to 1.2	292
  Percentage of adult patients getting regular hemodialysis at the center	98
  Percentage of pediatric patients getting regular hemodialysis at the center

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Fmc-Blythe Desert Dialysis with elevated calcium levels.

Patients with hypercalcemia	32
Hypercalcemia patient months	301
Hypercalcemia patients with serumcalcium greater than 10.2 mg	1
Patients with Serumphosphor	31
Patients with Serumphosphor less than 3.5 mg/dL	5
Patients with Serumphosphor from 3.5 to 4.5 mg/dL	26
Patients with Serumphosphor from 4.6 to 5.5 mg/dL	36
Patients with Serumphosphor from 5.6 to 7 mg/dL	24
Patients with Serumphosphor greater than 7 mg/dL	10

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries	33
Patient months included in arterial venous fistula and catheter summaries	229
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment	77
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer	5

The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.

Standard Hospitalization Summary Ratio(SHR) Year	January, 2016 - December, 2016
Patients in facility's Hospitalization Summary	23
Hospitalization Rate in facility	86.8 (As Expected)
Hospitalization Rate: Upper Confidence Limit	260.8
Hospitalization Rate: Lower Confidence Limit	31.5